Abstract
The immediate effects of estrogen deficiency are well known and include vasomotor, psychological, and genitourinary symptoms. However, the major importance of the long-term effects of estrogen deficiency, particularly on the skeleton and the cardiovascular system, is now being recognized. Thus, when using hormone replacement therapy (HRT), it is important to consider its effects on osteoporosis and cardiovascular disease as well as on symptom relief. There are several mechanisms whereby HRT can affect the cardiovascular system; these include both metabolic and direct arterial effects. An increased understanding of these mechanisms should allow us to develop optimal HRT regimens for the prevention and treatment of cardiovascular disease in women.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stevenson JC. Osteoporosis and cardiovascular disease in women: converging paths? Lancet 1990;336:1121–22.
LaCroix AZ, Haynes SG, Savage DD, Havlink RJ. Rose questionnaire angina among United States black, white and Mexican-American women and men. Am J Epidemiol 1989;129:669–86.
Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157–61.
Knopp RH. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol 1988;72:23S–30S.
Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83–90.
Proudler AJ, Felton C, Stevenson JC. Aging and the plasma insulin, glucose and C-peptide response to intravenous glucose in postmenopausal women. Clin Sci 1992;83:489–94.
Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 1993;23:466–73.
Ley CI, Lees B, Stevenson JC. Sex-and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992;55:950–54.
Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet 1991;338:839–42.
Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Folow-up Study. Circulation 1987;75:1102–09.
Falkeborn M, Persson I, Adami H-O et al. The risk of acute myocardial infarction after estrogen and estrogen/progestagen replacement. Br J Obstet Gynaecol 1992;99:821–28.
Adams MR, Kaplan JR, Manuck SB et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis 1990;10:1051–57.
Sullivan JM, Zwang RV, Hughes JP et al. Estrogen replacement and coronary artery disease. Arch Int Med 1990;150:2557–62.
Crook D, Stevenson JC, Progestogens, lipid metabolism and hormone replacement therapy. Br J Obstet Gynaecol 1991;98:749–50.
Bengtsson C, Björkelund C, Lapidus L, Lissner L. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. Br Med J 1993;307:1385–88.
Crook D, Cust MP, Gangar KF et al. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects of serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950–55.
Utermann G. The mysteries of lipoprotein (a). Science 1989;264:904–10.
Crook D, Sidhu M, Seed M, O’Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992;92:41–47.
Rymer J, Crook D, Sidhu M, Chapman M, Stevenson JC. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women. Acta Endocrinol 1993;128:259–62.
Farrish E, Rolton HA, Barnes JF, Hart DM. Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. Br Med J 1991;303:694.
Krauss RM. The tangled web of coronary risk factors. Am J Med 1991;90:36S–41S.
Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785–92.
Sack MN, Rader DJ, Cannon RO. Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269–70.
Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. Am J Clin Nutr 1956;4:20–34.
Stevenson JC, Lees B, Bruce R, Ley C, Crook D. Influence of body composition on lipid metabolism in postmenopausal women. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990:1837–38.
Ley CJ, Swan JW, Godsland IF, Walton C, Crook D, Stevenson JC. Insulin resistance, lipoproteins, body fat and hemostasis in non-obese males with angina and normal or abnormal coronary angiograms. J Am Coll Cardiol 1994;23:377–83.
Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 1994;105:209–16.
Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323–26.
Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.
Godsland IF, Gangar KF, Walton C et al. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993;42:846–53.
Fox J, George AJ, Newton JR et al. Effect of transdermal estradiol on the haemostatic balance of menopausal women. Maturitas 1993;18:55–64.
Winkler UH, Koslowski S, Oberhoff C, Schindler EM, Schindler AE. Changes of the dynamic equilibrium of hemostasis associated with the use of low dose oral contraceptives: a controlled study of cyproteroneacetate containing oral contraceptives combined with either 35 or 50 µg ethinylestradiol. Adv Contracept 1991;7:273–84.
Winkler UH. Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis 1992;6 suppl. 3:5–10.
Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal estrogen treatment and stroke: a prospective study. Br Med J 1988;297:519–22.
Ross RK, Pike MC, Mack TM, Henderson BE. Estrogen replacement therapy and cardiovascular disease. In: Drife JO, Studd JWW, editors. HRT and Osteoporosis. London: Springer-Verlag, 1990:209–22.
Lowe GDO, Greer IA, Cooke TG et al. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992;305:567–74.
Stevenson JC, Macdonald DWR, Warren RC, Booker MW, Whitehead MI. Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J 1986;293:1329–30.
Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circ Res 1990;81:1680–87.
Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17ß-estradiol in vitro. Br J Pharmacol 1991;104:1033–37.
Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen - a calcium antagonist effect? Lancet 1993;341:1264–65.
Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17ßestradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271–75.
Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17ß-estradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Stevenson, J.C. (1994). Effects of HRT on Metabolic Risk Factors for Cardiovascular Disease. In: Crosignani, P.G., Paoletti, R., Sarrel, P.M., Wenger, N.K., Meschia, M., Soma, M. (eds) Women’s Health in Menopause. Medical Science Symposia Series, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1024-2_3
Download citation
DOI: https://doi.org/10.1007/978-94-011-1024-2_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4446-2
Online ISBN: 978-94-011-1024-2
eBook Packages: Springer Book Archive